A detailed history of Janney Montgomery Scott LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 52,708 shares of PCRX stock, worth $897,617. This represents 0.0% of its overall portfolio holdings.

Number of Shares
52,708
Holding current value
$897,617
% of portfolio
0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$11.7 - $28.46 $616,683 - $1.5 Million
52,708 New
52,708 $793,000
Q2 2022

Aug 03, 2022

SELL
$51.49 - $81.64 $135,418 - $214,713
-2,630 Closed
0 $0
Q1 2022

May 04, 2022

BUY
$60.03 - $76.49 $157,878 - $201,168
2,630 New
2,630 $201,000

Others Institutions Holding PCRX

About Pacira BioSciences, Inc.


  • Ticker PCRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 45,824,200
  • Market Cap $780M
  • Description
  • Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...
More about PCRX
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.